US Broker Ratings

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Investor Consensus Points to 18.64% Upside Potential

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is capturing the attention of investors within the biotechnology sector, thanks to its impressive growth trajectory and robust pipeline of therapies aimed at central nervous..

Stevanato Group S.p.A. (STVN) Stock Analysis: Navigating a 23.31% Upside in the Healthcare Sector

Stevanato Group S.p.A. (NYSE: STVN) is a prominent player in the healthcare industry, specifically within the medical instruments and supplies sector. With a market capitalization of $6.38 billion, the Italian-based..

Oscar Health, Inc. (OSCR) Stock Report: Navigating a Rough Path with -22.24% ROE and Potential 20% Downside

Oscar Health, Inc. (NYSE: OSCR), a healthcare technology company headquartered in New York City, has been a notable player in the healthcare plans sector. With a market cap of $5.17..

Alkermes plc (ALKS) Investor Outlook: Exploring a Potential 48% Upside in Biopharma

Alkermes plc (NASDAQ: ALKS), a prominent name in the healthcare sector, specializes in developing and commercializing pharmaceutical products that address pressing medical needs. With its headquarters in Dublin, Ireland, the..

Glaukos Corporation (GKOS) Investor Outlook: Strong Buy Ratings Signal Potential 13.37% Upside

Glaukos Corporation (NYSE: GKOS), a key player in the healthcare sector specializing in medical devices, has been making waves with its innovative approach to treating ophthalmic conditions. With a market..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Exploring a 30.98% Potential Upside

Prestige Consumer Healthcare Inc. (NYSE: PBH), a prominent player in the healthcare sector, stands out in the drug manufacturers – specialty & generic industry. With a market capitalization of $2.93..

Viatris Inc. (VTRS): Investor Outlook Highlights 13.42% Potential Upside

Viatris Inc. (NASDAQ: VTRS) stands as a formidable player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a robust market capitalization of $12.34 billion,..

Rhythm Pharmaceuticals (RYTM) Stock Analysis: Navigating 16.42% Potential Upside in the Biotech Sector

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is capturing investor attention with its compelling growth prospects in the specialized field of rare neuroendocrine diseases. As a commercial-stage biopharmaceutical company, Rhythm is making..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Exploring the 125% Potential Upside

Soleno Therapeutics, Inc. (SLNO), a clinical-stage biopharmaceutical company, has recently caught the attention of investors with its substantial potential upside of 125.05%. The company, headquartered in Redwood City, California, operates..

Verona Pharma plc (VRNA) Investor Outlook: Navigating a $9.09 Billion Biotech with a Focus on Respiratory Therapies

Verona Pharma plc (NASDAQ: VRNA), a key player in the biotechnology sector, commands the attention of investors with its specialized focus on addressing unmet medical needs in respiratory diseases. With..

Teleflex Incorporated (TFX) Stock Analysis: Exploring a Potential 8.5% Upside in a Volatile Market

Teleflex Incorporated (NYSE: TFX), a prominent player in the healthcare sector specializing in medical instruments and supplies, is currently navigating a challenging market landscape. With a market capitalization of $5.06..

Tenet Healthcare Corporation (THC) Stock Analysis: Strong Analyst Consensus and a Promising 7.65% Upside

Tenet Healthcare Corporation (NYSE: THC), a key player in the healthcare sector, has caught the attention of investors with its robust market presence and promising growth potential. Headquartered in Dallas,..

Krystal Biotech, Inc. (KRYS): Analyst Consensus and Growth Potential in the Biotech Sector

Krystal Biotech, Inc. (NASDAQ: KRYS) is a rising star in the biotechnology sector, with a market capitalization of $6.32 billion. This commercial-stage biotech company is making waves with its innovative..

Genmab A/S (GMAB) Stock Analysis: Unveiling a 15% Upside Potential in the Biotech Sector

Genmab A/S (GMAB), a prominent player in the biotechnology sector, has been making waves with its robust pipeline and strategic collaborations. As a Denmark-based company, Genmab has carved out a..

Sarepta Therapeutics (SRPT) Stock Analysis: Is the Biotech Firm’s Current Valuation a Bargain?

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a prominent player in the biotechnology sector, has captured investor attention with its focus on RNA-targeted therapeutics and gene therapies, particularly for rare diseases like..

Telix Pharmaceuticals (TLX): Investor Outlook with a Promising 111% Upside

Telix Pharmaceuticals Limited (TLX), an innovative player in the biotechnology industry, has piqued investor interest with its promising pipeline in the field of radiopharmaceuticals. Headquartered in North Melbourne, Australia, Telix..

Moderna, Inc. (MRNA) Stock Analysis: Exploring a 43.23% Upside Potential Amid Market Challenges

Moderna, Inc. (NASDAQ: MRNA), a prominent player in the biotechnology sector, is known for its innovative approach to mRNA medicines. With a market capitalization of $10.15 billion, the company has..

Regencell Bioscience Holdings L (RGC) Stock Analysis: A Look Into Its Volatile Journey and Healthcare Ambitions

Regencell Bioscience Holdings Limited (NASDAQ: RGC) is an intriguing player in the healthcare sector, particularly within the niche of Traditional Chinese Medicine (TCM) targeting neurocognitive disorders. As an investor, understanding..

Revolution Medicines, Inc. (RVMD): A Promising Biotech Play with Strong Buy Ratings

Revolution Medicines, Inc. (NASDAQ: RVMD) is making substantial waves in the biotechnology sector, primarily focusing on precision oncology with a robust pipeline targeting RAS-addicted cancers. With a market capitalization of..

ICON plc (ICLR) Stock Analysis: Unveiling a 11.45% Potential Upside

ICON plc (NASDAQ: ICLR), a Dublin-based clinical research organization, is standing out in the healthcare sector with its expansive portfolio of development and commercialization services. Specializing in supporting the clinical..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds